Thin endometrium is a lesser known but deeply impactful condition affecting many women’s reproductive health. For women who are trying to conceive, a thin endometrial lining can be one of the most frustrating, confusing, and emotionally draining obstacles on the path to motherhood.
In this post, we’ll explore what a thin endometrium is, why it occurs, how it’s connected to conditions like Asherman syndrome and failed implantation, and—most importantly—how regenerative medicine may offer a safe, advanced, and science-backed solution.
What Is Thin Endometrium?
The endometrium is the inner lining of the uterus where the embryo implants and develops during pregnancy. In a healthy menstrual cycle, it thickens in response to hormones to prepare for a potential pregnancy.
A thin endometrium is usually defined as an endometrial lining measuring less than 7 mm, particularly during the window of implantation. This condition reduces the chances of a successful pregnancy—even when assisted reproductive technologies (ART) like IVF are used.
Why Does Thin Endometrium Happen?
Multiple factors can lead to a thin endometrium. Understanding the cause is essential for effective treatment:
Hormonal Imbalances
Low estrogen levels—due to aging, perimenopause, or certain hormonal contraceptives—can impair the endometrium’s ability to thicken.
Surgical Trauma or Infection
Procedures like dilation and curettage (D&C), uterine ablation, or infections can damage the endometrial stem cell layer. This damage may lead to scarring and poor regeneration.
Asherman Syndrome
Often overlooked, Asherman syndrome involves the formation of intrauterine adhesions (scar tissue) that disrupt normal endometrial function. It’s a key underlying cause of both thin endometrium and implantation failure
Chronic Inflammation
Conditions like chronic endometritis or pelvic inflammatory disease (PID) can interfere with endometrial receptivity and structure.
How Does Thin Endometrium Affect Fertility?
The impact is significant:
- Low implantation rates during IVF
- Recurrent pregnancy loss
- Cycle cancellations due to poor uterine lining response
Even with hormone therapy, some women show little or no improvement. This has created a critical need for innovative alternatives that go beyond hormone replacement.
Regenerative Medicine: A Game Changer for Thin Endometrium
Enter the future: regenerative medicine with stem cells. This cutting-edge field aims to repair and regenerate damaged tissues using the body’s own healing power.
How It Works
Autologous stem cells—specifically CD133+ cells derived from your own bone marrow—are mobilized, collected, and then reintroduced into the uterus via a minimally invasive procedure. These cells:
- Promote vascular growth (crucial for nourishing the endometrial lining)
- Stimulate cell proliferation in the basal layer
- Reduce scarring and fibrosis
- Improve receptivity for embryo implantation
The Role of PAULA Cell Therapy
Developed by leaders in reproductive science, PAULA Cell Therapy is a groundbreaking treatment offered by ENDORENEW (Before Asherman Therapy). It’s designed specifically for women with thin endometrium and Asherman syndrome who haven’t responded to conventional treatments.
Clinical trials have demonstrated:
- Improved endometrial thickness
- Enhanced menstrual patterns
- Increased implantation and pregnancy rates
Who Can Benefit From Stem Cell Therapy?
You may be a candidate if you:
- Have an endometrial thickness <7mm
- Have a history of failed IVF due to poor lining
- Have undergone uterine surgeries or experienced recurrent miscarriages
- Have been diagnosed with Asherman syndrome or thin endometrium
What to Expect From Treatment
PAULA Cell Therapy involves several outpatient visits including stem cell mobilization, apheresis (cell collection), and uterine infusion via catheterization. The process is safe, targeted, and avoids the need for invasive surgery or long-term hormonal drugs.
Follow-up includes hysteroscopic evaluation and potential guidance for natural conception or IVF.
Real Science, Real Results
With Orphan Drug Designation by the EMA and FDA, PAULA is backed by peer-reviewed studies and conducted under GMP-certified laboratory conditions.
Unlike traditional treatments, this therapy targets the root cause of a thin endometrium rather than simply alleviating symptoms.
Learn more or inquire about eligibility or send us an email at inquires@ashermantherapy.com